DATA BREACH: AT&T Customers May Be Entitled to Compensation

DATA BREACH: AT&T Customers May Be Entitled to Compensation

AT&T Inc. have disclosed a data breach affecting personal information of AT&T customers. Stating that the breach, affecting approximately 7.6 million current AT&T account holders and 65.4 million former account holders, exposed sensitive details including full names, email addresses, phone numbers, and social security numbers. This breach, originating from data sets dating back to 2019 or earlier

WHAT'S THIS ABOUT? Compensation may be available for AT&T account holders who received notice that their personal information had been breached.

WHY AM I ENTITLED TO COMPENSATION? Data breaches are serious matters that can cause long term damage. Hackers break into networks so that they can steal your personal information to sell it on the dark web or commit identity theft, financial theft, or other frauds.  The company may be liable for failing to secure your privacy.

HOW DO I KNOW IF I WAS AFFECTED? If you received a data breach notification letter from AT&T, you are affected.

Follow the link below to find out if you may be eligible for compensation.

Levi Korsinsky, LLP is investigating whether affected customers are entitled to compensation. If you have received a notice about the data breach, you may be entitled to compensation. There is no cost or obligation to participate. Follow the link below to find out:

https://bit.ly/3J1e0Wa

Levi & Korsinsky is a nationally recognized consumer advocacy law firm that has recovered hundreds of millions of dollars against large corporations. The firm's team of over 70 extraordinary attorneys and professionals have a winning track record going against the most powerful defense attorneys in the world and know how to maximize your compensation. The firm is a 100% contingency firm - we don'T get paid unless you get paid!  Please visit us at www.zlk.com for more information. Attorney Advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
https://zlk.com/

SOURCE: Levi & Korsinsky, LLP



View the original press release on accesswire.com

News Provided by ACCESSWIRE via QuoteMedia

T
The Conversation (0)

AT&T Inc.

The wireless business contributes about two thirds of AT&T's revenue following the spinoff of WarnerMedia.

The wireless business contributes about two thirds of AT&T's revenue following the spinoff of WarnerMedia. Keep Reading...
Yugo Metals

Government Approval Unlocks High-Grade Polymetallic Project at Petrovo (Sockovac)

Key SummaryThe Government of the Republic of Srpska (Bosnia and Herzegovina) has formally approved Yugo Metals' application for the 100%-owned Petrovo tenement (10km2), unlocking full access to advance what the Company believes is one of the most compelling high-grade polymetallic systems in... Keep Reading...
Silver Viper Hits 11.70 M @ 9.18 G/T Au And 352.0 G/T Ag Including 0.50 M @ 183.50 G/T Au And 6,850 G/T Ag While Infill Drilling At El Rubi And Expands The 5,000 M Drill Program At La Virginia Project In Sonora Mexico

Silver Viper Hits 11.70 M @ 9.18 G/T Au And 352.0 G/T Ag Including 0.50 M @ 183.50 G/T Au And 6,850 G/T Ag While Infill Drilling At El Rubi And Expands The 5,000 M Drill Program At La Virginia Project In Sonora Mexico

Silver Viper Minerals Corp. (TSXV: VIPR,OTC:VIPRF,OTC:VIPRF) (OTCQB: VIPRF) ("Silver Viper" or the "Company") is pleased to announce drill results from the previously announced drill program (October 2, 2025 Press Release) and highlights two anomalous exploration drill intercepts at El Molino,... Keep Reading...
InMed Pharmaceuticals Announces Positive Data from Human Brain Organoid Neuroinflammation Models Supporting the INM-901 Alzheimer's Disease Program

InMed Pharmaceuticals Announces Positive Data from Human Brain Organoid Neuroinflammation Models Supporting the INM-901 Alzheimer's Disease Program

Human Organoid Data Supports the Therapeutic Rationale for INM-901 Program Ahead of Human Clinical TrialsConsistent Anti-Inflammatory Effects Demonstrate Translation from Animal Models to Three-Dimensional Human Brain Tissue SystemsInMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the... Keep Reading...
Bunker Hill Announces Graduation to the Toronto Stock Exchange and on Track for Restart of Operations in June 2026

Bunker Hill Announces Graduation to the Toronto Stock Exchange and on Track for Restart of Operations in June 2026

Bunker Hill Mining Corp. ("Bunker Hill" or the "Company") (TSX-V: BNKR | OTCQB: BHLL) announced today that it has received approval for listing of the Company's shares of common stock (the "Common Shares") on the Toronto Stock Exchange (the "TSX") and remains on track for the restart of... Keep Reading...
Lahontan Closes $10.4 M First Tranche of Private Placement

Lahontan Closes $10.4 M First Tranche of Private Placement

Lahontan Gold Corp. (TSXV: LG,OTC:LGCXF) (OTCQB: LGCXF) (FSE:Y2F) (the "Company" or "Lahontan") is pleased to announce that, further to its press releases of March 12, 2026, and March 17, 2026, it has closed the first tranche of its non-brokered private placement through the issuance of... Keep Reading...

Interactive Chart

Latest Press Releases

Related News